Published in Immunity on February 01, 2001
Cancer immunotherapy: moving beyond current vaccines. Nat Med (2004) 17.61
Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A (2004) 4.70
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med (2005) 4.60
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol (2007) 3.18
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity (2013) 2.69
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol (2004) 2.54
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia (2010) 2.22
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc Natl Acad Sci U S A (2010) 2.01
Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model. Clin Cancer Res (2010) 1.92
Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity. J Immunol (2001) 1.83
Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med (2007) 1.83
Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol (2002) 1.74
IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci U S A (2002) 1.69
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model. Proc Natl Acad Sci U S A (2012) 1.64
Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies. PLoS One (2007) 1.61
ITK and IL-15 support two distinct subsets of CD8+ T cells. Proc Natl Acad Sci U S A (2006) 1.55
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey. J Clin Immunol (2007) 1.45
Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques. Blood (2011) 1.39
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J Clin Oncol (2014) 1.38
Survival adjustment of mature dendritic cells by IL-15. Proc Natl Acad Sci U S A (2005) 1.37
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A (2007) 1.35
Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep (2007) 1.31
The IL-2/IL-15 receptor systems: targets for immunotherapy. J Clin Immunol (2002) 1.30
Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine. J Immunol (2005) 1.26
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) (2009) 1.26
IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci U S A (2004) 1.25
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J Exp Med (2004) 1.22
Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets. J Transl Med (2006) 1.21
The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells. Immunity (2015) 1.20
IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci U S A (2001) 1.16
Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens (2008) 1.13
Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci U S A (2009) 1.11
IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc Natl Acad Sci U S A (2011) 1.10
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2. Cancer Immunol Immunother (2009) 1.09
Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol (2014) 1.07
Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc Natl Acad Sci U S A (2005) 1.06
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma. Clin Cancer Res (2012) 1.06
Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.05
The proliferative capacity of individual naive CD4(+) T cells is amplified by prolonged T cell antigen receptor triggering. J Exp Med (2002) 1.05
Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits. J Virol (2009) 1.04
IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo. Breast Cancer Res Treat (2009) 1.03
The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Arthritis Res (2002) 1.03
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model. J Transl Med (2006) 1.02
Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy. Neurol Clin (2008) 1.01
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. Front Oncol (2015) 1.01
Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J Virol (2002) 0.98
Routes to transplant tolerance versus rejection; the role of cytokines. Immunity (2004) 0.95
IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol (2008) 0.95
Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res Ther (2004) 0.95
Functions of IL-15 in anti-viral immunity: multiplicity and variety. Cytokine (2012) 0.94
Global transcriptional analysis delineates the differential inflammatory response interleukin-15 elicits from cultured human T cells. Exp Hematol (2007) 0.94
Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria. Front Immunol (2012) 0.94
IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat Rev Immunol (2015) 0.94
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood (2012) 0.93
Cytokine related therapies for autoimmune disease. Curr Opin Immunol (2008) 0.92
T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine (2011) 0.92
Promising novel immunotherapies and combinations for prostate cancer. Future Oncol (2009) 0.91
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res (2015) 0.91
Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells. Proc Natl Acad Sci U S A (2003) 0.91
Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation. Transplantation (2010) 0.91
Exogenous IL-15 in combination with IL-15R alpha rescues natural killer cells from apoptosis induced by chronic alcohol consumption. Alcohol Clin Exp Res (2008) 0.90
Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. Blood (2011) 0.89
Global transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor. BMC Med Genomics (2014) 0.87
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice. J Immunol (2012) 0.86
High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. Virology (2009) 0.86
MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis. J Immunol Methods (2009) 0.85
IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. J Leukoc Biol (2011) 0.85
Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. J Inflamm (Lond) (2009) 0.84
Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials. Cytotherapy (2007) 0.84
hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation. Int Immunol (2009) 0.83
IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals. J Clin Immunol (2010) 0.83
Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc Natl Acad Sci U S A (2002) 0.82
Interleukin-12 is the optimum cytokine to expand human Th17 cells in vitro. Clin Vaccine Immunol (2009) 0.81
Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers. Mediators Inflamm (2014) 0.81
Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers. Clin Vaccine Immunol (2007) 0.81
Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines. Clin Exp Immunol (2006) 0.80
Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses. PLoS One (2013) 0.80
Utilizing IL-12, IL-15 and IL-7 as Mucosal Vaccine Adjuvants. Lett Drug Des Discov (2006) 0.80
Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses. Biomol Concepts (2012) 0.79
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients. J Clin Immunol (2012) 0.79
In vitro assessment of choline dihydrogen phosphate (CDHP) as a vehicle for recombinant human interleukin-2 (rhIL-2). Cell Mol Bioeng (2012) 0.79
Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clin Exp Immunol (2002) 0.79
Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections. Clin Exp Immunol (2016) 0.78
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination. Front Immunol (2016) 0.78
Interleukin-7 and interleukin-15 for cancer. J Cancer (2014) 0.78
Characterisation and expression analysis of interleukin 2 (IL-2) and IL-21 homologues in the Japanese pufferfish, Fugu rubripes, following their discovery by synteny. Immunogenetics (2004) 0.78
Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV. Vaccine (2009) 0.78
IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells. Mol Cells (2011) 0.78
The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses. Front Immunol (2013) 0.77
T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation. Immunotherapy (2010) 0.77
High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosis. J Interferon Cytokine Res (2014) 0.77
Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates. J Heart Lung Transplant (2012) 0.77
Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells. Immunology (2002) 0.76
Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma. Clin Exp Immunol (2009) 0.76
IL-15-deficient mice develop enhanced allergic responses to airway allergen exposure. Clin Exp Allergy (2017) 0.76
The Zarit Burden Interview: a new short version and screening version. Gerontologist (2001) 3.95
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol (1999) 3.81
Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature (1995) 2.90
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A (2000) 2.80
A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet (1998) 2.44
Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet (1998) 2.34
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature (1998) 2.17
Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc Natl Acad Sci U S A (1987) 1.78
Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A (1990) 1.72
Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol (1998) 1.56
PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res (1995) 1.54
Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci U S A (1998) 1.54
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection. Mol Biol Med (1984) 1.41
Purification and structural and functional characterization of FhuA, a transporter of the Escherichia coli outer membrane. Biochemistry (1996) 1.38
Development of a food and activity record and a portion-size model booklet for use by 6- to 17-year olds: a review of focus-group testing. J Am Diet Assoc (2001) 1.35
The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15. J Biol Chem (2000) 1.33
Neuronal mechanisms of perceptual learning: changes in human brain activity with training in orientation discrimination. Neuroimage (1999) 1.32
Expression of interleukin 2 receptors on interleukin 3-dependent cell lines. J Immunol (1986) 1.29
Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection. Nature (1986) 1.25
Prediction of net energy value of feeds for growing pigs. J Anim Sci (1994) 1.21
Lymphocytic and collagenous colitis: an immunohistochemical study. Am J Gastroenterol (1996) 1.17
Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol (1999) 1.16
Metabolic utilization of energy and maintenance requirements in growing pigs: effects of sex and genotype. J Anim Sci (1999) 1.12
Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J Virol (2000) 1.12
Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet (1998) 1.11
TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines. J Immunol (1985) 1.11
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma. Q J Nucl Med Mol Imaging (2008) 1.08
Acquisition of CD80 (B7-1) by T cells. J Immunol (2001) 1.07
Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol (1998) 1.06
Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma. Cancer (1992) 1.05
Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus. J Immunol (1987) 1.05
Down-regulation of interleukin 1 (IL 1) receptor expression by IL 1 and fate of internalized 125I-labeled IL 1 beta in a human large granular lymphocyte cell line. J Immunol (1986) 1.04
Task modulation of brain activity related to familiar and unfamiliar face processing: an ERP study. Clin Neurophysiol (1999) 1.03
Differential effects on expression of IL-2 receptors (p55 and p70) by the HTLV-I pX DNA. Int J Cancer (1988) 1.02
Living with coeliac disease and a gluten-free diet: a Canadian perspective. J Hum Nutr Diet (2012) 1.01
The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness. J Biol Chem (1998) 1.01
Dynamic aspects of oxygen consumption and carbon dioxide production in swine. Br J Nutr (1997) 1.00
Effect of high temperature and feeding level on energy utilization in piglets. J Anim Sci (2001) 0.99
Comparison of health care professionals' self-assessments of standards of care and patients' opinions on the care they received in hospital: observational study. Qual Saf Health Care (2004) 0.98
Major determinants of fasting heat production and energetic cost of activity in growing pigs of different body weight and breed/castration combination. Br J Nutr (1998) 0.97
mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int J Obes (Lond) (2009) 0.96
Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes. Proc Natl Acad Sci U S A (1989) 0.96
In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis. J Antimicrob Chemother (1989) 0.96
Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15. Cancer Res (2000) 0.93
Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient. J Immunol (1992) 0.92
An examination of factors believed to be associated with infantile obesity. Am J Clin Nutr (1979) 0.92
Energy utilization in pigs selected for high and low residual feed intake. J Anim Sci (2010) 0.92
Energy utilization of low-protein diets in growing pigs. J Anim Sci (2001) 0.91
Rat lymphoid cell lines producing human T cell leukemia virus. II. Constitutive expression of rat interleukin 2 receptor. J Exp Med (1985) 0.91
Implementation of a province-wide computerized network in Quebec: the FAMUS Project. MD Comput (1995) 0.90
Effect of body weight on net energy value of feeds for growing pigs. J Anim Sci (1994) 0.89
Interleukin 1 alpha mRNA in virus-transformed T and B cells. Biochem Biophys Res Commun (1986) 0.89
The effect of dietary fibre on energy utilisation and partitioning of heat production over pregnancy in sows. Br J Nutr (2000) 0.89
Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analogues. Biochem Biophys Res Commun (1987) 0.88
Energetic efficiency of starch, protein and lipid utilization in growing pigs. J Nutr (2001) 0.88
Expression of CD44 in premalignant and malignant Barrett's oesophagus. Histopathology (1998) 0.87
Dam methyltransferase from Escherichia coli: kinetic studies using modified DNA oligomers: nonmethylated substrates. Biol Chem (1997) 0.87
Two distinct affinity binding sites for IL-1 on human cell lines. J Immunol (1989) 0.86
Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2. Cytokine (1999) 0.86
The TEAM evaluation approach to Project FAMUS, a pan-Canadian risk register for primary care. Proc Annu Symp Comput Appl Med Care (1992) 0.85
Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2. Proc Natl Acad Sci U S A (1994) 0.85
Effect of thermal heat stress on energy utilization in two lines of pigs divergently selected for residual feed intake. J Anim Sci (2013) 0.85
Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood (1995) 0.84
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma. Genes Chromosomes Cancer (2013) 0.84
Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Br J Dermatol (2001) 0.83
Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization. Histopathology (2000) 0.83
The expression of IL-2R alpha-chain is enhanced by activation of adenylate cyclase in large granular lymphocytes and natural killer cells. J Immunol (1991) 0.83
Impact of the Higgins Nutrition Intervention Program on birth weight: a within-mother analysis. J Am Diet Assoc (1989) 0.83
Effect of high temperature on feeding behaviour and heat production in group-housed young pigs. Br J Nutr (2001) 0.83
Interleukin-2 receptor/p55(Tac)-inducing activity in porcine follicular fluids. Endocrinology (1989) 0.82
Effects of feed restriction and subsequent refeeding on energy utilization in growing pigs. J Anim Sci (2006) 0.82
Dietary management of urea cycle disorders: European practice. Mol Genet Metab (2013) 0.82
Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non-mucinous tumours. Histopathology (2004) 0.81
PET study of the human foveal fixation system. Hum Brain Mapp (1999) 0.81
The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells. J Exp Med (2000) 0.81
Subunit structure of the high and low affinity human interleukin-15 receptors. Eur Cytokine Netw (2000) 0.81
Modelling heat production and energy balance in group-housed growing pigs exposed to low or high ambient temperatures. Br J Nutr (2001) 0.80
Multiple mixed adenoma-focal nodular hyperplasia of the liver associated with spontaneous intrahepatic porto-systemic shunt: a new type of vascular malformation associated with the multiple focal nodular hyperplasia syndrome? Histopathology (2006) 0.80
IL-2 receptor gene activation by ATL-derived factor (ADF). Adv Exp Med Biol (1987) 0.80
Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes (1999) 0.79
Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent. Mol Immunol (1992) 0.79
PET study of human voluntary saccadic eye movements in darkness: effect of task repetition on the activation pattern. Eur J Neurosci (1998) 0.79
Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum. Am J Clin Pathol (2001) 0.79
Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor. Int Immunol (1993) 0.79
Effect of feed intake on heat production and protein and fat deposition in milk-fed veal calves. Animal (2009) 0.78
70-75 kd molecules expressed on LGL and T cells recognized by a mitogenic monoclonal antibody YTA-1; co-modulation and functional association with the interleukin 2 receptor p75. Int Immunol (1990) 0.78
ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J (1994) 0.78
Effect of protein and lysine levels in the diet on body gain composition and energy utilization in growing pigs. J Anim Sci (1987) 0.78
Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol (1997) 0.78
Effect of solid feed on energy and protein utilization in milk-fed veal calves. J Anim Sci (2008) 0.77
Digestibility and metabolic utilisation of dietary energy in adult sows: influence of addition and origin of dietary fibre. Br J Nutr (2002) 0.77
[A comparison between group-average and individual evoked potential analysis]. Neurophysiol Clin (1999) 0.77
Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses. Int Immunol (1992) 0.77
Relationship between composition of lymphoid cell infiltrates in the liver and replication status in chronic hepatitis B: an immunohistochemical study. Am J Clin Pathol (1996) 0.77
Effects of acute exposure to aluminum on cognition in humans. J Toxicol Environ Health A (2007) 0.77